Today: 8 June 2026
Diageo share price today: DGE stock nudges higher after insider buy, with results in focus
11 February 2026
1 min read

Diageo share price today: DGE stock nudges higher after insider buy, with results in focus

London, Feb 11, 2026, 09:29 GMT — Regular session.

  • Diageo shares picked up roughly 0.6% early in London, building on Tuesday’s rebound.
  • Chair John Manzoni picked up a small batch of shares, filings show. Other disclosures highlighted executives buying through their plans.
  • All eyes now turn to the Feb. 25 interim results, as investors hunt for new signals on demand and guidance.

Diageo shares picked up another 0.6% in early London hours on Wednesday, landing near 1,825 pence after surging 3.3% a day earlier. The stock moved in a band between 1,805 and 1,833 pence.

This comes as Diageo approaches a high-stakes reporting period—small insider dealing disclosures like these tend to stick out just as the stock looks for footing. Investors aren’t aligned; the recent rebound hasn’t settled the debate over whether the slowdown in spirits is actually letting up.

Diageo plans to release its interim results for the half-year to Dec. 31 on Feb. 25, per its investor calendar. CEO Sir Dave Lewis and CFO Nik Jhangiani will lead a webcast and Q&A session that same morning.

Chair John Alexander Manzoni snapped up 365 shares on Tuesday, paying £17.99 apiece in a transaction totaling roughly £6,566.

On the same day, several senior execs — CFO Jhangiani among them — picked up modest amounts of Diageo shares via the company’s employee plan, salary deductions funding the purchases. They also got matching shares as part of the program, according to separate filings.

Diageo’s U.S. shares finished up roughly 2% at $99.08 in New York, setting a stronger tone for London investors heading into their own session.

Still, the comeback isn’t guaranteed if major markets don’t pick up. Back in November, Diageo lowered both its sales and profit outlooks, blaming a weaker U.S. consumer climate. The company also signaled that organic net sales this year would be flat, maybe a little down.

Risk sentiment is mixed halfway through the week, as traders eye new U.S. payroll figures while softer retail sales numbers have already rattled confidence in the consumer, according to a Reuters markets note.

Eyes turn to Diageo’s interim results dropping Feb. 25, a key moment for investors waiting on fresh signals about the company’s outlook and what’s happening with demand.

Stock Market Today

  • Singapore Stocks Slide 1.9% Amid Global Tech Sell-off and Middle East Tensions
    June 8, 2026, 5:33 AM EDT. Singapore's Straits Times Index (STI) dropped 1.9% to 4,955.47 on June 8, pressured by a global slump in technology shares and escalating Middle East conflicts. Major tech stocks, including AEM and UMS, fell between 3-4%, while precision engineering and AI-related firm InnoTek declined over 4%. Regional markets fell sharply, with South Korea's Kospi down 8.1%, Japan's Nikkei by 4%, and Taiwan's benchmark by 3.5%. Key chipmakers Samsung Electronics and SK Hynix saw steep losses of 9.5% and 6.5%, respectively. The tech sell-off followed Broadcom's weaker-than-expected revenue guidance, raising fears of an AI investment bubble. Local banks DBS, OCBC, and UOB also declined amid rising inflation concerns driven by higher oil prices and geopolitical risks. The volatile market reflects investor caution ahead of SpaceX's Nasdaq IPO slated for June 12.

Latest articles

Hyperscale Data Stock Faces 21-Cent Deadline After Friday’s 25% Slide

Hyperscale Data Stock Faces 21-Cent Deadline After Friday’s 25% Slide

8 June 2026
Hyperscale Data’s $0.21/share buyback offer sits 39% above Friday’s $0.1510 close, with the tender expiring late Monday and covering up to 5.1% of shares; the company cites a “material disconnect” with net book value at $0.26/share, while ending its ATM stock-sale program and holding $51.8M in Bitcoin as of May 31.
Zealand Pharma Shares Sink 25% After Trial Results

Zealand Pharma Shares Sink 25% After Trial Results

8 June 2026
Zealand Pharma shares plunged 26.02% to 241.40 Danish crowns after investors focused on a 19% discontinuation rate for Boehringer’s obesity drug survodutide in the SYNCHRONIZE-1 trial, far higher than the 2.9% for placebo, despite strong fat-loss data, making the stock the worst performer on Europe’s STOXX 600 in early trade.
Intel’s AI Stock Run Stalls; Monday Premarket Move Fails to Settle It

Intel’s AI Stock Run Stalls; Monday Premarket Move Fails to Settle It

8 June 2026
Intel shares rose 1.6% to $100.74 in pre-market trading Monday, partly rebounding from Friday’s 7.9% drop that followed a strong U.S. jobs report and a tech selloff; investors now face a key test as Intel’s AI partnerships with Foxconn and others lack visible orders or financial details, while options pricing signals potential for another 9% stock move this week amid inflation data and shifting rate expectations.
Nvidia’s $5 Trillion Valuation Gets Put to the Test Monday

Nvidia’s $5 Trillion Valuation Gets Put to the Test Monday

8 June 2026
Nvidia shares hovered near Friday’s 6% drop and $300 billion market cap loss despite new South Korean AI deals, as chip stocks reeled from fears of higher U.S. rates and regulatory risks; investors await Monday’s open to see if fresh partnerships can offset sector volatility and valuation pressure.
Nokia drops after fast AI rally, traders stay focused

Nokia rally stalls as traders sell tech stocks after AI push

8 June 2026
Nokia shares plunged 2.98% in Helsinki to 12.690 euros, extending losses as investors dumped AI-linked tech stocks amid rising oil prices and rate fears; U.S. ADRs dropped 13.48% Friday, while no new operating update was given and Nokia issued 500 million euros in new debt, with the next key earnings test set for July 23.
Legal & General share price slips as AI disruption worries keep UK insurers on edge
Previous Story

Legal & General share price slips as AI disruption worries keep UK insurers on edge

QVC Group stock (QVCGA) plunges on creditor-talks report as bankruptcy risk comes into view
Next Story

QVC Group stock (QVCGA) plunges on creditor-talks report as bankruptcy risk comes into view

Go toTop